December 25, 2014 5:23 PM ET

Pharmaceuticals

Company Overview of CGI Pharmaceuticals, Inc.

Company Overview

CGI Pharmaceuticals, Inc., a development-stage pharmaceutical company, discovers and develops small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications; and Syk, a regulator of mast cell, monocyte/macrophage, and B-cell functions. The company was formerly known as Cellular Genomics, Inc. and changed its name to CGI Pharmaceuticals, Inc. in September, 2005. The company was founded in 1998 and is headquartered in Branford, Connecticut. As of July 8, 2010, CGI Pharmaceuticals, Inc. operates as a subsidiary of Gilead Sciences Inc.

36 East Industrial Road

Branford, CT 06405

United States

Founded in 1998

Phone:

203-315-1222

Fax:

203-488-7838

Key Executives for CGI Pharmaceuticals, Inc.

Member of the Scientific Advisory Board and Founder
Chief Operating Officer and Chief Business Officer
Age: 59
Director of Research Informatics
Vice President of Medical Research
Senior Director of Preclinical Biology
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Ansun Biopharma, Inc. United States
Biolife LLC United States
OncoSource Rx, LLC United States
Ives Health Company, Inc. United States
ProlX Pharmaceuticals Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CGI Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.